JP2013525473A5 - - Google Patents

Download PDF

Info

Publication number
JP2013525473A5
JP2013525473A5 JP2013508559A JP2013508559A JP2013525473A5 JP 2013525473 A5 JP2013525473 A5 JP 2013525473A5 JP 2013508559 A JP2013508559 A JP 2013508559A JP 2013508559 A JP2013508559 A JP 2013508559A JP 2013525473 A5 JP2013525473 A5 JP 2013525473A5
Authority
JP
Japan
Prior art keywords
group
ortho
meta
optionally substituted
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013508559A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013525473A (ja
JP5812541B2 (ja
Filing date
Publication date
Priority claimed from HU1000243A external-priority patent/HUP1000243A2/hu
Application filed filed Critical
Publication of JP2013525473A publication Critical patent/JP2013525473A/ja
Publication of JP2013525473A5 publication Critical patent/JP2013525473A5/ja
Application granted granted Critical
Publication of JP5812541B2 publication Critical patent/JP5812541B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013508559A 2010-05-06 2011-05-06 8−ヒドロキシキノリン誘導体 Active JP5812541B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HUP1000243 2010-05-06
HU1000243A HUP1000243A2 (en) 2010-05-06 2010-05-06 8-hidroxy-quinoline derivatives
PCT/HU2011/000043 WO2011148208A1 (en) 2010-05-06 2011-05-06 8-hydroxy-quinoline derivatives

Publications (3)

Publication Number Publication Date
JP2013525473A JP2013525473A (ja) 2013-06-20
JP2013525473A5 true JP2013525473A5 (https=) 2014-06-26
JP5812541B2 JP5812541B2 (ja) 2015-11-17

Family

ID=89989711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013508559A Active JP5812541B2 (ja) 2010-05-06 2011-05-06 8−ヒドロキシキノリン誘導体

Country Status (21)

Country Link
US (1) US8871937B2 (https=)
EP (1) EP2566849B1 (https=)
JP (1) JP5812541B2 (https=)
KR (1) KR101837974B1 (https=)
CN (1) CN102985407B (https=)
AU (1) AU2011256989B2 (https=)
CA (1) CA2798419C (https=)
CY (1) CY1122426T1 (https=)
DK (1) DK2566849T3 (https=)
EA (1) EA021026B1 (https=)
ES (1) ES2761832T3 (https=)
HR (1) HRP20192278T1 (https=)
HU (2) HUP1000243A2 (https=)
MX (1) MX337999B (https=)
NZ (1) NZ603967A (https=)
PL (1) PL2566849T3 (https=)
PT (1) PT2566849T (https=)
RS (1) RS59678B1 (https=)
SI (1) SI2566849T1 (https=)
SM (1) SMT201900710T1 (https=)
WO (1) WO2011148208A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP1500098A2 (hu) * 2015-03-09 2016-09-28 Avidin Kft 8-hidroxikinolin származékok új enantiomerjei és szintézisük
WO2017066245A1 (en) * 2015-10-12 2017-04-20 Health Research, Inc. Methods for inducing apoptosis in cancer cells
CN105367553A (zh) * 2015-12-04 2016-03-02 广东工业大学 一种他克林-8-羟(胺)基喹啉衍生物及其应用
HUP1600234A2 (en) 2016-04-05 2017-12-28 Mta Termeszettudomanyi Kutatokoezpont Mdr-reversing 8-hydroxy-quinoline derivatives
WO2024073624A2 (en) * 2022-09-28 2024-04-04 The Research Foundation For The State University Of New York Antiproliferative betti bases and prodrugs thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544972B1 (en) 1997-09-25 2003-04-08 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
US6184210B1 (en) 1997-10-10 2001-02-06 Cytovia, Inc. Dipeptide apoptosis inhibitors and the use thereof
CA2319131A1 (en) 1998-01-26 1999-07-29 Walter H. Moos Mitochondria protecting agents for treating mitochondria associated diseases
US6737511B1 (en) 1999-08-16 2004-05-18 The United States Of America As Represented By The Department Of Health And Human Services Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
CN1235875C (zh) 1999-08-27 2006-01-11 西托维亚公司 取代的α-羟基酸天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途
US6890896B1 (en) 1999-11-18 2005-05-10 Ceremedix, Inc. Compositions and methods for counteracting effects of reactive oxygen species and free radicals
US6476048B1 (en) 1999-12-07 2002-11-05 Inotek Pharamaceuticals Corporation Substituted phenanthridinones and methods of use thereof
US6531464B1 (en) 1999-12-07 2003-03-11 Inotek Pharmaceutical Corporation Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives
US6534651B2 (en) 2000-04-06 2003-03-18 Inotek Pharmaceuticals Corp. 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
GB0011095D0 (en) 2000-05-08 2000-06-28 Black James Foundation astrin and cholecystokinin receptor ligands (III)
AU2002213174A1 (en) 2000-10-13 2002-04-22 Massaharu Akao Treatment of apoptotic cell death
US6552076B2 (en) 2000-12-15 2003-04-22 Mitokor Compounds for altering mitochondrial function and cellular responses
US7601846B2 (en) 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
EP1414948B1 (en) 2001-07-10 2009-09-16 Biogen Idec Inc. Inhibition of apoptosis process and improvement of cell performance
DE10144153A1 (de) 2001-09-07 2003-03-27 Newfrey Llc Halteclip mit versetzten Rastfingern
SG148850A1 (en) 2002-02-13 2009-01-29 Beth Israel Hospital Methods of treating vascular disease
JP2007501857A (ja) 2003-02-28 2007-02-01 イノテック ファーマシューティカルズ コーポレーション 四環系ベンズアミド誘導体およびその使用方法
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
WO2004105700A2 (en) 2003-05-28 2004-12-09 Guildford Pharmaceuticals, Inc. Compounds, methods and pharmaceutical compositions for inhibiting parp
CA2851972C (en) 2004-01-23 2015-06-23 Cornell Research Foundation, Inc. Methods for reducing oxidative damage
TWI375673B (en) 2005-04-11 2012-11-01 Abbott Lab 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
WO2007059230A2 (en) 2005-11-15 2007-05-24 Abbott Laboratories Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
US7528174B2 (en) 2006-01-06 2009-05-05 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Selective targeting agents for mitochondria
RU2009106461A (ru) * 2006-07-25 2010-08-27 Энвиво Фармасьютикалз, Инк. (Us) Хинолиновые производные
EP3085367A3 (en) * 2007-03-20 2017-01-25 Brandeis University Compositions for the diagnosis, treatment, and prevention of amyotrophic lateral sclerosis and related
US8183236B2 (en) * 2007-04-12 2012-05-22 University Of Southern California Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics
EP2148944A1 (en) 2007-05-25 2010-02-03 Burnham Institute for Medical Research Inhibitors of thapsigargin-induced cell death
US8138356B2 (en) * 2007-10-16 2012-03-20 Angiogeney, Inc. Chemical inhibitors of inhibitors of differentiation
US10301265B2 (en) * 2008-05-28 2019-05-28 Virginia I. Roxas-Duncan Small molecule inhibitors of botulinum neurotoxins
US8658170B2 (en) * 2010-01-06 2014-02-25 Joseph P. Errico Combination therapy with MDM2 and EFGR inhibitors
AU2011204368B2 (en) * 2010-01-06 2014-11-27 Joseph P. Errico Methods and compositions of targeted drug development

Similar Documents

Publication Publication Date Title
JP2020530487A5 (https=)
JP2019518766A5 (https=)
JP2010520264A5 (https=)
RU2013147400A (ru) Способ получения производных кето-бензофурана
JP2016505614A5 (https=)
JP2017508733A5 (https=)
JP2014508811A5 (https=)
JP2013525473A5 (https=)
JP2015509535A5 (https=)
JP2015508092A5 (https=)
JP2016121196A5 (https=)
JP2014521625A5 (https=)
JP2010520265A5 (https=)
JP2017504635A5 (https=)
JP2010513494A5 (https=)
JP2013544860A5 (https=)
JP2017533237A5 (https=)
JP2011517443A5 (https=)
JP2017519754A5 (https=)
SI3102573T1 (en) SUBSTITUTED TIAZOL OR OXASOL AS ANTAGONISTS OF THE RECEPTOR P2X7
JP2009538910A5 (https=)
JP2013511511A5 (https=)
JP2018530582A5 (https=)
JP2015500842A5 (https=)
JP2016503403A5 (https=)